748 drugs are set the maximum fee limit;!

The era of unified purchasing channels and price payment for medical insurance drugs is coming Where will the varieties be rushed out of the hospital? Recently, Qingdao Medical Security Bureau issued the list of the second batch of drugs with the maximum cost limit According to the list of products circulated, a total of 31 varieties were determined with the maximum price limit According to the statistics of the public platform of drugstore, 611 product regulations involving 256 enterprises will be implemented from October 1 This time, the injection is set as the highest limit, including Xueshuantong, Xuesaitong, cefoperazone sodium and Sulbactam Sodium for injection, as well as common disease drugs such as Qiangli loquat dew and Ganmaoqingre granules In addition, the first batch of products with a maximum fee limit were 17 varieties, involving 137 product specifications of 80 enterprises In this way, the maximum drug cost limit of the smallest preparation unit of 748 product specifications was determined for the two batches In May this year, Shandong provincial drug centralized purchase network released the document "opinions on trial online drug centralized purchase by private medical institutions", which was the first to allow private medical institutions under medical insurance agreement management and chain retail drugstores (agreement medical institutions) to purchase drugs online through Shandong provincial drug centralized purchase platform, and apply for an account in the public trading center on June 1 Officially implemented on January 1 Now, Qingdao is the first city to issue a document to further determine the price ceiling of medical insurance payment for these products According to the notice issued by Qingdao Medical Insurance Bureau in August, the medical insurance department will set the medical insurance payment standard according to the price not higher than the price of the centralized purchase platform, and the medical insurance department will pay the medical insurance drugs of all designated medical institutions (including public hospitals and non-public hospitals) and pharmacies according to the price For the varieties without network, refer to the drug network price at the same quality level When the drug purchase of designated medical insurance institutions is included in the centralized purchase, the payment standard is determined While the medical insurance department effectively controls the medical expenses, the problem that the industry has to face is: where will the out of hospital varieties go? Previously, due to bidding and price reduction and other reasons, many of the bidding varieties have turned to the outside of the hospital to open up the outside market In the case that the medical insurance payment standards are not unified, these outside of the hospital varieties still have the price advantage, relying on the price to maintain the profit space and market Now, when health care standards are unified, this advantage is facing challenges According to the documents of Qingdao City, as long as it is a medical insurance drug, if the payment standard is set according to the centralized purchase price, if the drug is not linked to the Internet, the price of the online product at the same quality level will be referred, that is, whether it is linked to the Internet or not, the payment standard of medical insurance will be determined, and according to the payment standard of medical insurance determined by the smallest preparation unit, the price loophole of the online product that is not linked to the Internet can still be high will be closed, and the price loophole of the online product will be closed Different packaging brings huge price gap Although private hospitals and retail can still sell products at a higher price than the medical insurance payment price, it must be explained In order to attract patients, non-public hospital channel prices will gradually converge with public hospitals Or, in this case, in order to promote the sales of drugs, we must give more profit space to channels, and reduce the profit space of products again, and the living space of varieties outside the hospital will be further compressed At present, more and more retail institutions and hospitals designated by medical insurance are included in the centralized purchase of drugs After being in Shandong Province, Zhejiang Pharmaceutical machinery purchasing center issued a notice to open purchasing platform for six provincial pharmaceutical chain drugstore groups, including inte Yinian, Huadong pharmacy, guokong pharmacy, Xinyi pharmacy, Yunkai Yamei pharmacy and Jiuzhou pharmacy In order to better control the medical expenses, the unified medical insurance payment standard like Qingdao is expected to become the standard action For out of hospital varieties, it is not good at all, especially those whose price factors are squeezed out of the hospital may be more difficult to survive.